Bjorn E Oskarsson, MD

Dr. Björn Oskarsson, stems from Stockholm, Sweden and he received his medical degree from University of Lund where he developed an interest in nerve regeneration. He continued his Neurology, Neuromuscular Medicine, EMG and Neuromuscular pathology training at and had his first faculty appointment at University of Colorado. Subsequently, he founded the multidisciplinary ALS clinic at University of California Davis and in 2016 he was recruited to Mayo Clinic in Florida to lead the ALS Center of Excellence. Working in collaboration with the Mayo Clinic Neuroscience department, his research focuses on understanding the basic principles of motor nerve degeneration and trying new treatments in pursuit of therapeutics that may slow, stop, or even reverse this process. His clinical focus includes the diagnosis and treatment of ALS and providing personalized medicine to improve patient outcomes. His is enthusiastic about advancing care for people with ALS. This commitment extends to the development and implementation of innovative diagnostic tools, such as neurofilament light biomarker studies and 7-Tesla MRI. His work also includes data, biofluid and tissue collection and involvement in a range of clinical trials, from single-patient antisense oligonucleotide projects to leading large-scale, international Phase III industry trials and a NINDS Expanded Access Program.